Literature DB >> 21481830

Uncovering an intermediate phenotype associated with rs2200733 at 4q25 in lone atrial fibrillation.

Adele H Goodloe1, Kathleen J Herron, Timothy M Olson.   

Abstract

Genomewide association studies have reproducibly identified rs2200733T on chromosome 4q25 as a risk factor for the most common sustained arrhythmia, atrial fibrillation (AF). The biologic basis for cardiac electrical instability conferred by this noncoding variant is unknown. The aim of this study was to investigate potential relations between rs2200733 versus clinical and electrocardiographic traits in a cohort of patients with early-onset AF who lack traditional risk factors. Congruent with previous reports, the minor T allele was overrepresented in subjects with lone AF. All genotype groups were statistically similar for age at diagnosis, gender distribution, family history, body mass index, AF type, ventricular rate, QRS duration, corrected QT interval, and use of PR interval--prolonging medications. However, a novel association was identified between the TT genotype and duration of the PR interval. The TT group had a mean PR interval of 189.5 ± 35.8 ms in comparison to mean PR intervals of 172.0 ± 29.0 and 171.0 ± 27.1 ms for the CT and CC groups, respectively (p = 0.013 and p = 0.0056). In conclusion, PR interval length, an established risk factor for AF, represents an rs2200733-associated intermediate phenotype.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21481830     DOI: 10.1016/j.amjcard.2011.02.326

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 2.  Genetics of atrial fibrillation: from families to genomes.

Authors:  Ingrid E Christophersen; Patrick T Ellinor
Journal:  J Hum Genet       Date:  2015-05-21       Impact factor: 3.172

3.  Genotype-phenotype associations in atrial fibrillation: meta-analysis.

Authors:  Zhen Hu; Deling Zou
Journal:  J Interv Card Electrophysiol       Date:  2018-11-17       Impact factor: 1.900

4.  There is power in numbers--even/especially in genomic medicine.

Authors:  David R Van Wagoner; Mina K Chung
Journal:  Can J Cardiol       Date:  2012-02-09       Impact factor: 5.223

5.  A common variant on chromosome 4q25 is associated with prolonged PR interval in subjects with and without atrial fibrillation.

Authors:  Matthew J Kolek; Babar Parvez; Raafia Muhammad; M Benjamin Shoemaker; Marcia A Blair; Tanya Stubblefield; Gayle A Kucera; Joshua C Denny; Dan M Roden; Dawood Darbar
Journal:  Am J Cardiol       Date:  2013-10-03       Impact factor: 2.778

6.  Creation and Validation of an EMR-based Algorithm for Identifying Major Adverse Cardiac Events while on Statins.

Authors:  Wei-Qi Wei; Qiping Feng; Peter Weeke; William Bush; Magarya S Waitara; Otito F Iwuchukwu; Dan M Roden; Russell A Wilke; Charles M Stein; Joshua C Denny
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2014-04-07

7.  The 4q25, 1q21, and 16q22 polymorphisms and recurrence of atrial fibrillation after pulmonary vein isolation.

Authors:  Marek Kiliszek; Edward Kozluk; Maria Franaszczyk; Piotr Lodzinski; Agnieszka Piatkowska; Rafal Ploski; Grzegorz Opolski
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

8.  SNP rs3825214 in TBX5 is associated with lone atrial fibrillation in Chinese Han population.

Authors:  Xiaobiao Zang; Shulong Zhang; Yunlong Xia; Sisi Li; Fenfen Fu; Xiuchun Li; Fan Wang; Rongfeng Zhang; Xiaochen Tian; Lianjun Gao; Jiaying Zhang; Yanzong Yang; Xin Tu; Qing Wang
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

Review 9.  Genetics of Atrial Fibrillation.

Authors:  Julien Feghaly; Patrick Zakka; Barry London; Calum A MacRae; Marwan M Refaat
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.